MIRA Pharmaceuticals Inc.

NASDAQ: MIRA · Real-Time Price · USD
1.51
0.04 (2.72%)
At close: Aug 15, 2025, 3:59 PM
1.48
-1.97%
After-hours: Aug 15, 2025, 07:51 PM EDT

MIRA Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 8.53M n/a n/a
Gross Profit
n/a -8.53M n/a n/a
Operating Income
-8.02M -8.53M -7.05M -2.15M
Interest Income
n/a n/a n/a n/a
Pretax Income
-7.85M -11.98M -7.06M -2.18M
Net Income
-7.85M -11.98M -7.06M -2.18M
Selling & General & Admin
4.71M 6.95M 2.99M 770.12K
Research & Development
3.31M 1.57M 2.35M 684.45K
Other Expenses
n/a 0.00 -1.7M -697.6K
Operating Expenses
8.02M 8.53M 7.05M 2.15M
Interest Expense
165.67K 3.46M 10.25K 24.37K
Selling & Marketing Expenses
n/a 453.55K n/a n/a
Cost & Expenses
n/a 8.53M 7.05M 2.15M
Income Tax Expense
n/a n/a -7.05K -2.15K
Shares Outstanding (Basic)
15.44M 18.57M 14.75M 14.75M
Shares Outstanding (Diluted)
15.44M 18.57M 14.75M 14.75M
EPS (Basic)
-0.51 -0.65 -0.48 -0.15
EPS (Diluted)
-0.51 -0.65 -0.48 -0.15
EBITDA
-7.85M n/a -7.05M -2.15M
EBIT
-7.69M -8.53M -7.05M -2.15M
Depreciation & Amortization
-165.67K 8.53M 7.05M 2.15M